| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.2 | 0.005 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.006 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |